Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Most U.S. Sunscreens Not So Hot, Reflecting FDA Failures – EWG

This article was originally published in The Tan Sheet

Executive Summary

Sunscreen products earned low marks in EWG’s 2013 guide because FDA’s regulation of the category is not rigorous enough, the group says. But the Personal Care Products Council cautions that consumers may get the wrong message from EWG and choose to not use sunscreen.

You may also be interested in...



PASS Presses FDA To Repair TEA Process, Facilitate Sunscreen Reviews

The Public Access to SunScreens Coalition plans to work with FDA, lawmakers and stakeholders to facilitate review of sunscreen active ingredients. The group proposes user fees as one method of ensuring FDA has resources to complete sunscreen ingredient evaluations, some pending as time and extent applications since 2002.

PASS Presses FDA To Repair TEA Process, Facilitate Sunscreen Reviews

The Public Access to SunScreens Coalition plans to work with FDA, lawmakers and stakeholders to facilitate review of sunscreen active ingredients. The group proposes user fees as one method of ensuring FDA has resources to complete sunscreen ingredient evaluations, some pending as time and extent applications since 2002.

Senators Push FDA For SPF Cap, Spray Sunscreen Review

Nine Democrats led by Senator Jack Reed ask FDA to resolve sunscreen issues that remain in regulatory limbo. FDA needs to clarify “misconceptions about misleadingly high SPF labels beyond 50, where the increase in UV protection is relatively small,” the senators suggest.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS106413

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel